Pheochromocytoma associated with neurofibromatosis type 1: Concepts and current trends

World Journal of Surgical Oncology

Volumn 8, Issue , 2010, Pages

  Zografos, George N ^a   Vasiliadis, George K ^a   Zagouri, Flora ^b   Aggeli, Chrysanthi ^a   Korkolis, Dimitris ^a   Vogiaki, Sophia ^a   Pagoni, Matina K ^a   Kaltsas, Gregory ^a   Piaditis, George ^a  

^a G GENNIMATAS GENERAL HOSPITAL   (Greece)

^b ALEXANDRA HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE; GLYCERYL TRINITRATE; HYDRALAZINE; METADRENALIN; VANILMANDELIC ACID;

ADRENAL TUMOR; ADRENALECTOMY; ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; EXCISION; EXTRASYSTOLE; FLUSHING; HISTOPATHOLOGY; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; LAPAROSCOPIC SURGERY; MALE; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PHEOCHROMOCYTOMA; POSTOPERATIVE PERIOD; SKIN NODULE; SURGICAL APPROACH; URINE LEVEL; LAPAROSCOPY; PATHOLOGY;

ADRENAL GLAND NEOPLASMS; ADRENALECTOMY; ADULT; HUMANS; LAPAROSCOPY; MAGNETIC RESONANCE IMAGING; MALE; NEUROFIBROMATOSIS 1; PHEOCHROMOCYTOMA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77949426887     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-8-14     Document Type: Article

References (30)

1. Pacak K, Linehan WM, Eisenhofer G, Walther MM, Goldstein DS. Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma. Ann Intern Med 2001, 134:315-329.
2. Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, Ali A, Giovagnetti M, Opocher G, Angeli A. A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab 2000, 85:637-44. 10.1210/jc.85.2.637, 10690869.
3. Bravo EL, Tagle R. Pheochromocytoma: state-of-the-art and future prospects. Endocr Rev 2003, 24:539-553. 10.1210/er.2002-0013, 12920154.
4. Bryant J, Farmer J, Kessler LJ, Townsend RR, Nathanson KL. Pheochromocytoma: the expanding genetic differential diagnosis. J Natl Cancer Inst 2003, 95(16):1196-204.
5. Ponder BAJ. Multiple endocrine neoplasia type 2. The metabolic and molecular bases of inherited disease 2001, 931-942. New York: McGraw-Hill, Scriver CR Beaudet AL, Sly WS, Valle D, 8.
6. Theos A, Korf BR, . American college of physicians; American physiological society Pathophysiology of neurofibromatosis type 1. Ann Intern Med 2006, 144(11):842-9. American college of physicians; American physiological society.
7. Walther MM, Herring J, Enquist E, Keiser HR, Linehan WM. Von Recklinghausen's disease and pheochromocytomas. J Urol 1999, 162:1582-6. 10.1016/S0022-5347(05)68171-2, 10524872.
8. Heniford B, Arca M, Walsh M, Gill IS. Laparoscopic adrenalectomy for metastasis or cancer. Sem Surg Oncol 1999, 16:293-306.
9. Zografos GN, Farfaras A, Aggeli C, Kontogeorgos G, Pagoni M, Vogiati S, Vasiliadis G, Papastratis G. Laparoscopic adrenalectomy for large adrenal metastasis from contralateral renal cell carcinoma. JSLS 2007, 11:261-265.
10. Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, Conte-Devolx B, Falchetti A, Gheri RG, Libroia A, Lips CJ, Lombardi G, Mannelli M, Pacini F, Ponder BA, Raue F, Skogseid B, Tamburrano G, Thakker RV, Thompson NW, Tomassetti P, Tonelli F, Wells SA, Marx SJ. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 2001, 86(12):5658-71. 10.1210/jc.86.12.5658, 11739416.
11. Robinson MF, Furst EJ, Nunziata V, Brandi ML, Ferrer JP, Martins Bugalho MJ, di Giovanni G, Smith RJ, Donovan DT, Alford BR, et al. Characterization of the clinical features of five families with hereditary primary cutaneous lichen amyloidosis and multiple endocrine neoplasia type 2. Henry Ford Hosp Med J 1992, 40:249-252.
12. Williams ED, Pollock DJ. Multiple mucosal neuromata with endocrine tumours: a syndrome allied to Von Recklinghausen's disease. J Pathol Bacteriol 1996, 91:71-80.
13. Pomares FJ, Canas R, Rodriguez JM, Hernandez AM, Parrilla P, Tebar FJ. Differences between sporadic and multiple endocrine neoplasia type 2A pheochromocytoma. Clin Endocrinol (Oxf.) 1998, 48:195-200. 10.1046/j.1365-2265.1998.3751208.x, 9579232.
14. Marini F, Falchetti A, Del Monte F, Carbonell Sala S, Tognarini I, Luzi E, Brandi ML. Multiple endocrine neoplasia type 2. Orphanet J Rare Dis 2006, 1:45. 10.1186/1750-1172-1-45, 1654141, 17105651.
15. Brasfield RD, Das Gupta T. Von Recklinghausen's disease: A clinicopathologic study. Ann Surg 1972, 175:86-104. 1355163, 4621893.
16. Toledo SP, dos Santos MA, Toledo Rde A, Lourenço DM. Impact of RET proto-oncogene analysis on the clinical management of multiple endocrine neoplasia type 2. Clinics (Sao Paulo) 2006, 61(1):59-70.
17. Koch CA, Vortmeyer AO, Huang SC, Alesci S, Zhuang Z, Pacak K. Genetic aspects of pheochromocytoma. Endocr Regul 2001, 35(1):43-52.
18. Korf BR. Malignancy in neurofibromatosis type 1. Oncologist 2000, 5(6):477-85. 10.1634/theoncologist.5-6-477, 11110599.
19. Korf BR. Neurofibromas and malignant tumors of the peripheral nervous system. Neurofibromatosis: Phenotype, Natural History, and Pathogenesis 1999, 142-61. Baltimore: Johns Hopkins Univ Pr, Friedman JM, Gutmann DH, MacCollin M, Riccardi VM, 3.
20. Listernick R, Louis DN, Packer RJ, Gutmann DH. Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force. Ann Neurol 1997, 41:143-9. 10.1002/ana.410410204, 9029062.
21. Woodward ER, Maher ER. Von Hippel-Lindau disease and endocrine tumour susceptibility. Endocr Relat Cancer 2006, 13(2):415-25. 10.1677/erc.1.00683, 16728571.
22. Shuin T, Yamasaki I, Tamura K, Okuda H, Furihata M, Ashida S. Von Hippel-Lindau disease: molecular pathological basis, clinical criteria, genetic testing, clinical features of tumors and treatment. Jpn J Clin Oncol 2006, 36(6):337-43. 10.1093/jjco/hyl052, 16818478.
23. Walther MM, Reiter R, Keiser HR, Choyke PL, Venzon D, Hurley K, Gnarra JR, Reynolds JC, Glenn GM, Zbar B, Linehan WM. Clinical and genetic characterization of pheochromocytoma in von Hippel-Lindau families: comparison with sporadic pheochromo-cytoma gives insight into natural history of pheochromocytoma. J Urol 1999, 162:659-64. 10.1097/00005392-199909010-00004, 10458336.
24. Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1993, 260:1317-20. 10.1126/science.8493574, 8493574.
25. Vargas H, Kavoussi L. Laparoscopic adrenalectomy: a new standard of care. Urology 1997, 49(5):673-8. 10.1016/S0090-4295(97)00083-6, 9145969.
26. Gagner M, Lacroix A. Laparoscopic adrenalectomy in Cushings' syndrome and pheochromocytoma. N Eng J Med 1992, 327:1023.
27. Zografos GN, Markou A, Ageli C, Kopanakis N, Koutmos S, Kaltsas G, Piaditis G, Papastratis G. Laparoscopic surgery for adrenal tumors. A retrospective analysis. Hormones 2006, 5(1):52-56.
28. Kercher KW, Novitsky YW, Park A, Matthews BD, Litwin DE, Heniford BT. Laparoscopic curative resection of pheochromocytomas. Ann Surg 2005, 241(6):919-26. 10.1097/01.sla.0000164175.26785.06, 1357171, 15912041.
29. Elashry OM, Clayman RV, Soble JJ, McDougall EM. Laparoscopic adrenalectomy for solitary metachronous contralateral adrenal metastasis from renal cell carcinoma. J Urol 1997, 157(4):1217-22. 10.1016/S0022-5347(01)64927-9, 9120905.
30. Thompson GB, Grant CS, van Heerden JA, Schlinkert RT, Young WF, Farley DR, Ilstrup DM. Laparoscopic versus open posterior adrenalectomy: a case-control study of 100 patients. Surgery 1997, 6:132-136.